{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:58:35Z","timestamp":1740135515495,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T00:00:00Z","timestamp":1548633600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006259","name":"Teva Pharmaceutical Industries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006259","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12890-019-0783-0","type":"journal-article","created":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T07:03:13Z","timestamp":1548658993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Associations of AMP and adenosine induced dyspnea sensation to large and small airways dysfunction in asthma"],"prefix":"10.1186","volume":"19","author":[{"given":"Claire A.","family":"Cox","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilse M.","family":"Boudewijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiaan J.","family":"Vroegop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siebrig","family":"Schokker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne J.","family":"Lexmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henderik W.","family":"Frijlink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Hagedoorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith M.","family":"Vonk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn P.","family":"Farenhorst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick H. T.","family":"ten Hacken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huib A. M.","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"van den Berge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,28]]},"reference":[{"key":"783_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S1081-1206(10)60353-5","volume":"103","author":"DW Cockcroft","year":"2009","unstructured":"Cockcroft DW, Davis B. Direct and indirect challenges in the clinical assessment of asthma. Ann Allergy Asthma Immunol. 2009;103:363\u20139 quiz 369\u2013372, 400.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"783_CR2","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1042\/cs0980681","volume":"98","author":"R Ottanelli","year":"2000","unstructured":"Ottanelli R, Rosi E, Romagnoli I, Ronchi MC, Lanini B, Grazzini M, et al. Perception of bronchoconstriction and bronchial hyper-responsiveness in asthma. Clin Sci (Lond). 2000;98:681\u20137.","journal-title":"Clin Sci (Lond)"},{"key":"783_CR3","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3109\/15412555.2011.560127","volume":"8","author":"LN Segal","year":"2011","unstructured":"Segal LN, Goldring RM, Oppenheimer BW, Stabile A, Reibman J, Rom WN, et al. Disparity between proximal and distal airway reactivity during methacholine challenge. COPD. 2011;8:145\u201352.","journal-title":"COPD"},{"key":"783_CR4","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1164\/ajrccm\/146.2.396","volume":"146","author":"PL Brand","year":"1992","unstructured":"Brand PL, Rijcken B, Schouten JP, Ko\u00ebter GH, Weiss ST, Postma DS. Perception of airway obstruction in a random population sample. Relationship to airway hyperresponsiveness in the absence of respiratory symptoms. Am Rev Respir Dis. 1992;146:396\u2013401.","journal-title":"Am Rev Respir Dis"},{"key":"783_CR5","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.jaci.2012.12.1567","volume":"131","author":"E Wiel Van Der","year":"2013","unstructured":"Van Der Wiel E, ten Hacken NHT, Postma DS, Van Den Berge M. Small-airways dysfunction associates with respiratory symptoms and clinical features of asthma: a systematic review. J Allergy Clin Immunol. 2013;131:646\u201357.","journal-title":"J Allergy Clin Immunol"},{"key":"783_CR6","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.rmed.2013.08.009","volume":"107","author":"T Perez","year":"2013","unstructured":"Perez T, Chanez P, Dusser D, Devillier P. Small airway impairment in moderate to severe asthmatics without significant proximal airway obstruction. Respir Med. 2013;107:1667\u201374.","journal-title":"Respir Med"},{"key":"783_CR7","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000242113","volume":"80","author":"T Takeda","year":"2010","unstructured":"Takeda T, Oga T, Niimi A, Matsumoto H, Ito I, Yamaguchi M, et al. Relationship between small airway function and health status, dyspnea and disease control in asthma. Respiration. 2010;80:120\u20136.","journal-title":"Respiration"},{"key":"783_CR8","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1111\/all.12510","volume":"69","author":"E Wiel Van Der","year":"2014","unstructured":"Van Der Wiel E, Postma DS, Van Der Molen T, Schiphof-Godart L, ten Hacken NHT, Van Den Berge M. Effects of small airway dysfunction on the clinical expression of asthma: a focus on asthma symptoms and bronchial hyper-responsiveness. Allergy Eur J Allergy Clin Immunol. 2014;69:1681\u20138.","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"key":"783_CR9","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.rmed.2007.08.007","volume":"102","author":"AH Mansur","year":"2008","unstructured":"Mansur AH, Manney S, Ayres JG. Methacholine-induced asthma symptoms correlate with impulse oscillometry but not spirometry. Respir Med. 2008;102:42\u20139.","journal-title":"Respir Med"},{"key":"783_CR10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1111\/all.12242","volume":"68","author":"IM Boudewijn","year":"2013","unstructured":"Boudewijn IM, Telenga ED, Van Der Wiel E, Van Der Molen T, Schiphof L, ten Hacken NHT, et al. Less small airway dysfunction in asymptomatic bronchial hyperresponsiveness than in asthma. Allergy Eur J Allergy Clin Immunol. 2013;68:1419\u201326.","journal-title":"Allergy Eur J Allergy Clin Immunol."},{"key":"783_CR11","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.jaci.2006.07.012","volume":"118","author":"DW Cockcroft","year":"2006","unstructured":"Cockcroft DW, Davis BE. Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol. 2006;118:551\u20139 quiz 560-1.","journal-title":"J Allergy Clin Immunol"},{"key":"783_CR12","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1183\/09031936.03.00008403","volume":"21","author":"GF Joos","year":"2003","unstructured":"Joos GF, O\u2019Connor B, Anderson SD, Chung F, Cockcroft DW, Dahl\u00e9n B, et al. Indirect airway challenges. Eur Respir J. 2003;21:1050\u201368.","journal-title":"Eur Respir J"},{"key":"783_CR13","doi-asserted-by":"publisher","first-page":"65p","DOI":"10.1042\/cs070065Pb","volume":"70","author":"W Chan","year":"1986","unstructured":"Chan W, Cushley MJ, Holgate ST. The effect of inhaled adenosine 5\u2032-monophosphate (AMP) on airway calibre in normal and asthmatic subjects. Clin Sci. 1986;70:65p\u20136p.","journal-title":"Clin Sci"},{"key":"783_CR14","doi-asserted-by":"publisher","first-page":"18S","DOI":"10.1378\/chest.10-0088","volume":"138","author":"DW Cockcroft","year":"2010","unstructured":"Cockcroft DW. Direct challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest. 2010;138:18S\u201324S.","journal-title":"Chest"},{"key":"783_CR15","doi-asserted-by":"crossref","unstructured":"Lexmond AJ, Boudewijn IM, Hagedoorn P, Schokker S, Cox CA, Vonk JM, et al. Bronchial provocation testing can be improved by using dry powder adenosine instead of nebulized AMP. Am J Respir Crit Care Med. 2017;197:391-4.","DOI":"10.1164\/rccm.201704-0715LE"},{"key":"783_CR16","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1517\/14656566.2012.638917","volume":"13","author":"A Sverrild","year":"2012","unstructured":"Sverrild A, Porsbjerg C, Backer V. The use of inhaled mannitol in the diagnosis and management of asthma. Expert Opin Pharmacother. 2012;13:115\u201323.","journal-title":"Expert Opin Pharmacother"},{"key":"783_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-9921-6-144","volume":"6","author":"JD Brannan","year":"2005","unstructured":"Brannan JD, Anderson SD, Perry CP, Freed-Martens R, Lassig AR, Charlton B, et al. The safety and efficacy of inhaled dry powder mannitol as a bronchial provocation test for airway hyperresponsiveness: a phase 3 comparison study with hypertonic (4.5%) saline. Respir Res. 2005;6:1\u201312.","journal-title":"Respir Res"},{"key":"783_CR18","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1089\/jamp.2012.1021","volume":"26","author":"AJ Lexmond","year":"2013","unstructured":"Lexmond AJ, Hagedoorn P, Frijlink HW, de Boer AH. Challenging the two-minute tidal breathing challenge test. J Aerosol Med Pulm Drug Deliv. 2013;26:380\u20136.","journal-title":"J Aerosol Med Pulm Drug Deliv"},{"key":"783_CR19","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1183\/09031936.00204109","volume":"37","author":"J Cohen","year":"2011","unstructured":"Cohen J, Postma DS, Douma WR, Vonk JM, De B a H, ten Hacken NHT. Particle size matters: diagnostics and treatment of small airways involvement in asthma. Eur Respir J. 2011;37:532\u201340.","journal-title":"Eur Respir J"},{"key":"783_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.ejpb.2013.06.027","volume":"86","author":"AJ Lexmond","year":"2014","unstructured":"Lexmond AJ, Hagedoorn P, van der Wiel E, ten Hacken NHT, Frijlink HW, de Boer AH. Adenosine dry powder inhalation for bronchial challenge testing, part 1: inhaler and formulation development and in vitro performance testing. Eur J Pharm Biopharm. 2014;86:105\u201314.","journal-title":"Eur J Pharm Biopharm"},{"key":"783_CR21","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1164\/rccm.200410-1414OC","volume":"172","author":"OS Usmani","year":"2005","unstructured":"Usmani OS, Biddiscombe MF, Barnes PJ. Regional lung deposition and bronchodilator response as a function of \u03b2 2 -agonist particle size. Am J Respir Crit Care Med. 2005;172:1497\u2013504.","journal-title":"Am J Respir Crit Care Med"},{"key":"783_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.rmed.2017.07.005","volume":"130","author":"CA Cox","year":"2017","unstructured":"Cox CA, Boudewijn IM, Vroegop SJ, Schokker S, Lexmond AJ, Frijlink HW, et al. Extrafine compared to non-extrafine particle inhaled corticosteroids in smokers and ex-smokers with asthma. Respir Med. 2017;130:35\u201342.","journal-title":"Respir Med"},{"key":"783_CR23","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.ejpb.2014.04.008","volume":"88","author":"AJ Lexmond","year":"2014","unstructured":"Lexmond AJ, van der Wiel E, Hagedoorn P, Bult W, Frijlink HW, ten Hacken NHT, et al. Adenosine dry powder inhalation for bronchial challenge testing, part 2: proof of concept in asthmatic subjects. Eur J Pharm Biopharm. 2014;88:148\u201352.","journal-title":"Eur J Pharm Biopharm"},{"key":"783_CR24","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1159\/000343629","volume":"84","author":"OS Usmani","year":"2012","unstructured":"Usmani OS. Treating the small airways. Respiration. 2012;84:441\u201353.","journal-title":"Respiration"},{"key":"783_CR25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0099-1767(00)90093-X","volume":"26","author":"KR Kendrick","year":"2000","unstructured":"Kendrick KR, Baxi SC, Smith RM. Usefulness of the modified 0-10 Borg scale in assessing the degree of dyspnea in patients with COPD and asthma. J Emerg Nurs. 2000;26:216\u201322.","journal-title":"J Emerg Nurs"},{"key":"783_CR26","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.coph.2006.02.002","volume":"6","author":"M Caruso","year":"2006","unstructured":"Caruso M, Holgate ST, Polosa R. Adenosine signalling in airways. Curr Opin Pharmacol Elsevier. 2006;6:251\u20136.","journal-title":"Curr Opin Pharmacol Elsevier"},{"key":"783_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/1465-9921-7-139","volume":"7","author":"NK Burki","year":"2006","unstructured":"Burki NK, Alam M, Lee L-Y. The pulmonary effects of intravenous adenosine in asthmatic subjects. Respir Res. 2006;7:139.","journal-title":"Respir Res"},{"key":"783_CR28","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1152\/physiol.00022.2009","volume":"24","author":"T Eckle","year":"2009","unstructured":"Eckle T, Koeppen M, Eltzschig HK. Role of extracellular adenosine in acute lung injury. Physiology. 2009;24:298\u2013306.","journal-title":"Physiology"},{"key":"783_CR29","doi-asserted-by":"crossref","unstructured":"Paintal AS. Sensations from J receptors. Am J Phys. 1995;10:238-43.","DOI":"10.1152\/physiologyonline.1995.10.5.238"},{"key":"783_CR30","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1152\/japplphysiol.00155.2006","volume":"101","author":"J Widdicombe","year":"2006","unstructured":"Widdicombe J. Reflexes from the lungs and airways: historical perspective. J Appl Physiol. 2006;101:628\u201334.","journal-title":"J Appl Physiol"},{"key":"783_CR31","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1016\/j.rmed.2007.01.019","volume":"101","author":"S Kleis","year":"2007","unstructured":"Kleis S, Chanez P, Delvaux M, Louis R. Perception of dyspnea in mild smoking asthmatics. Respir Med. 2007;101:1426\u201330.","journal-title":"Respir Med"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0783-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12890-019-0783-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-019-0783-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,27]],"date-time":"2020-01-27T19:07:16Z","timestamp":1580152036000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpulmmed.biomedcentral.com\/articles\/10.1186\/s12890-019-0783-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,28]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["783"],"URL":"https:\/\/doi.org\/10.1186\/s12890-019-0783-0","relation":{},"ISSN":["1471-2466"],"issn-type":[{"type":"electronic","value":"1471-2466"}],"subject":[],"published":{"date-parts":[[2019,1,28]]},"assertion":[{"value":"12 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All subjects provided written informed consent. The OLiVIA study was approved by the ethics committee of the University Medical Center Groningen on March 19th, 2013 and is known under reference number M13.133950.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CC, IB, SV, SS, AL, JV, MF and NtH have nothing to disclose. HF reports other from MEDA, other from AstraZeneca, outside the submitted work. PH has a patent on the Novolizer with royalties paid, a patent on the Genuair with royalties paid, and a patent on the Twincer with royalties paid. HK reports that his institution has received grants from TEVA in relation to the submitted work, as well as consultancy fees from Novartis, GlaxoSmithKline, Fluidda, AstraZeneca, and Boehringer Ingelheim outside the submitted work. MvdB reports grants paid to the University from Astra Zeneca, TEVA, GSK, Chiesi, outside the submitted work.The current work was sponsored by supported by TEVA pharmaceutical Industries Ltd., which was in no way involved in study design, writing or reviewing of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"23"}}